A case of double leukemia: chronic myeloid leukemia intolerant to imatinib and chronic lymphocytic leukemia

被引:0
|
作者
Rocchi, Miriana [1 ]
机构
[1] UO Med Interna 1, Osped F Lotti, Pontedera, PI, Italy
关键词
chronic myeloid leukemia; imatinib resistance; chronic lymphocytic leukemia; nilotinib;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML) are the most common leukemias of the elderly. However, the sequential occurrence of CML followed by CLL in the same patient is extremely rare. We present a report of a 70-year-old man who developed CLL six years after the diagnosis of CML in molecular, cytogenetic and morphologic remission. The diagnosis of CLL is confirmed by peripheral lymphocytosis. The first line therapy in CML in chronic phase is still imatinib, but in the present case the patient was intolerant to imatinib, therefore he switched to nilotinib after few months.
引用
收藏
页码:13 / 16
页数:4
相关论文
共 50 条
  • [1] A Rare Patient with Chronic Myeloid Leukemia and Chronic Lymphocytic Leukemia
    Bhagavathi, Sharathkumar
    Borromeo, Vidal
    Desai, Harsha
    Crisan, Domnita
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2008, 38 (04) : 405 - 409
  • [2] Simultaneous occurrence of chronic myeloid leukemia and chronic lymphocytic leukemia: Report of an unusual case
    Rahman, Khaliqur
    George, Seena
    Mangal, Sriyash
    Mehta, Anurag
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2013, 56 (04) : 453 - 456
  • [3] The occurrence of chronic lymphocytic leukemia after chronic phase of chronic myeloid leukemia: case report and literature review
    Crisan, Ana Manuela
    Badelita, Sorina Nicoleta
    Jardan, Cerasela
    Vasilache, Ecaterina Didona
    Dobrea, Camelia-Marioara
    Gheorghe, Anca
    Talmaci, Rodica
    Arion, Constantin Virgiliu
    Bardas, Alexandru
    Gaman, Amelia Maria
    Coriu, Daniel
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2015, 56 (03) : 1145 - 1151
  • [4] Response to Dasatinib in a Patient with Concomitant Chronic Myeloid Leukemia and Chronic Lymphocytic Leukemia
    Serpa, Mariana
    Bendit, Israel
    Seguro, Fernanda
    Xavier, Flavia
    Cavalcante, Marcela
    Steinbaum, Daniel
    Nardinelli, Luciana
    Aldred, Vera Lucia
    de Paula, Henrique Moura
    Dorlhiac-Llacer, Pedro Enrique
    ACTA HAEMATOLOGICA, 2010, 124 (02) : 105 - 109
  • [5] Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phase
    Giles, F. J.
    Kantarjian, H. M.
    le Coutre, P. D.
    Baccarani, M.
    Mahon, F-X
    Blakesley, R. E.
    Gallagher, N. J.
    Gillis, K.
    Goldberg, S. L.
    Larson, R. A.
    Hochhaus, A.
    Ottmann, O. G.
    LEUKEMIA, 2012, 26 (05) : 959 - 962
  • [6] Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phase
    F J Giles
    H M Kantarjian
    P D le Coutre
    M Baccarani
    F-X Mahon
    R E Blakesley
    N J Gallagher
    K Gillis
    S L Goldberg
    R A Larson
    A Hochhaus
    O G Ottmann
    Leukemia, 2012, 26 : 959 - 962
  • [7] Three Hematologic Malignancies in the Same Patient: Chronic Lymphocytic Leukemia, Followed by Chronic Myeloid Leukemia and Acute Myeloid Leukemia
    Fattizzo, Bruno
    Radice, Tommaso
    Cattaneo, Daniele
    Pomati, Mauro
    Barcellin, Wilma
    Iurlo, Alessandra
    CLINICAL LABORATORY, 2014, 60 (11) : 1929 - 1932
  • [8] Response of concomitant chronic myelogenous leukemia and chronic lymphocytic leukemia to imatinib mesylate
    Yoon, Ju-Yoon
    Kumar, Rajat
    Aloyz, Raquel
    Johnston, James B.
    LEUKEMIA RESEARCH, 2011, 35 (09) : E179 - E180
  • [9] Coexistence of Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
    Milosevic, Ivana
    TURKISH JOURNAL OF HEMATOLOGY, 2016, 33 (04) : 353 - 354
  • [10] Simultaneous Occurrence of Chronic Lymphocytic and Chronic Myeloid Leukemia
    Katovic, Sandra Kojic
    Vasilj, Ankica
    Maricevic, Ivana
    Carzavec, Dubravka
    Juric, Silva Curic
    COLLEGIUM ANTROPOLOGICUM, 2010, 34 (02) : 653 - 655